MarketLens

OptimizeRx's Q4 Beat: A Closer Look at the Numbers

5 months ago

SHARE THIS ON:

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Decoding the CEO's Recent Share Sales: A Closer Look at Rambus Insider Activity

4 months ago

EIG's Q4 2025 Earnings: A Deeper Dive into the Numbers

6 months ago

Is Marvell Technology's Q4 Beat a Game Changer for Investors

5 months ago

Has Target Finally Turned the Corner After Its Q4 Earnings Beat

5 months ago

TECH Q4 Earnings Meet Estimates, Revenues Surpass, Stock Rises

Bio-Techne's Q4 revenues beat estimates, driven by strong organic growth in Diagnostics and Spatial Biology, while its Merck deal remains in focus. The stock rose following the earnings release.

TECH

Stock News•1 week ago

OptimizeRx Corporation (OPRX) Q2 2026 Earnings Call Transcript

OptimizeRx reported Q2 2026 results, with revenue rising 12% to $22.5M, driven by strong demand for its digital health engagement platform. Management raised full-year guidance, citing improved client...

OPRX

Stock News•2 weeks ago

Will Pharma and Specialty Demand Boost Cardinal Health's Q4 Results?

Cardinal Health heads into Q4 earnings with pharma, specialty and higher-margin businesses in focus, as investors watch whether growth offsets pricing headwinds. Results could hinge on segment mix.

CAH

Stock News•1 months ago

UnitedHealth Stock Hits 2026 High on Strong Earnings, Rosy Outlook

UnitedHealth shares hit a 2026 high after Q4 earnings and revenue topped Wall Street estimates, driven by strong performance in its Optum health-services unit.

UNH